William Benton Jones

CRVS

SEE REMARKS · CORVUS PHARMACEUTICALS, INC. · CIK 0001664506

FILING MIX · LIFETIME91%/9%

BUYS

SELLS

TOTAL VALUE

$118.2K

COMPANIES

ACTIVE SINCE

Dec 2020

HOLDINGS NOW

400,000

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

3 backtested trades · 8 horizons

Forward-return performance of every backtestable P/S trade by William Benton Jones, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	3	+66.67%	+6.86%	+0.64%	+6.22%	+9.63%	—
14d	3	+100.00%	+16.64%	+1.77%	+14.88%	+16.76%	—
30d	3	+100.00%	+13.80%	+3.05%	+10.75%	+12.73%	—
60d	3	+0.00%	-4.42%	+7.49%	-11.91%	-12.43%	—
90d	3	+66.67%	+27.71%	+1.61%	+26.10%	+47.16%	—
180d	3	+100.00%	+313.35%	+12.95%	+300.41%	+365.20%	—
1y	3	+100.00%	+83.59%	+14.68%	+68.92%	+65.84%	—
2y	3	+100.00%	+656.79%	+48.52%	+608.27%	+665.03%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

CRVS · 400,000 shares · as of Dec 4, 2025

Trading cadence · quarterly flow

BUY ● SELL ●

2020

2021

2022

2023

2024

2025

FLOW · 10 buys / 1 sellsCOVERAGE · 21 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	400,000	—	—	400,000	Dec 4, 2025	Dec 8, 2025 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASE See Remarks	19,357	$3.50	$67.7K	173,130	Jun 4, 2025	Jun 6, 2025 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	SALE See Remarks	19,357	—	—	0	Jun 4, 2025	Jun 6, 2025 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	300,000	—	—	300,000	Dec 20, 2024	Dec 20, 2024 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASE See Remarks	20,000	$1.73	$34.6K	153,773	May 6, 2024	May 7, 2024 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASE See Remarks	19,357	—	—	19,357	May 6, 2024	May 7, 2024 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	200,000	—	—	200,000	Dec 6, 2023	Dec 8, 2023 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASE See Remarks	20,000	$0.79	$15.8K	133,773	Dec 20, 2022	Dec 20, 2022 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	160,000	—	—	160,000	Aug 11, 2022	Aug 15, 2022 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	160,000	—	—	160,000	Sep 9, 2021	Sep 13, 2021 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	160,000	—	—	160,000	Dec 16, 2020	Dec 17, 2020 ↗	View →

Other insiders · CRVS

Loading peer insiders…

About this filer

CIK 0001664506

ROLE

See Remarks

PRIMARY

CRVS

COMPANIES

ACTIVE SINCE

Dec 2020

MARKETPEEL · /INSIDER/0001664506DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

William Benton Jones

The morning brief, before the bell.